Dual effects of TNFα on nerve fiber formation from ventral mesencephalic organotypic tissue cultures

Brain Research

Volumn 1215, Issue , 2008, Pages 30-39

  Marschinke, Franziska ^a   Strömberg, Ingrid ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

Dopamine; Nerve fiber formation; TNF ; Ventral mesencephalon

Indexed keywords

MONOCLONAL ANTIBODY KI 67; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; TYROSINE 3 MONOOXYGENASE; DOPAMINE; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ARTICLE; ASTROCYTE; CELL COUNT; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; DOPAMINERGIC NERVE CELL; FEMALE; FETUS; IMMUNOHISTOCHEMISTRY; MACROGLIA; MESENCEPHALON; NERVE FIBER GROWTH; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE CULTURE; ANIMAL; CELL MOTION; CULTURE TECHNIQUE; CYTOLOGY; GLIA; GROWTH, DEVELOPMENT AND AGING; IN VITRO STUDY; METABOLISM; NERVE CELL; NERVE FIBER; PHYSIOLOGY; SPRAGUE DAWLEY RAT; TIME;

ANIMALS; CELL CULTURE TECHNIQUES; CELL MOVEMENT; DOPAMINE; IMMUNOHISTOCHEMISTRY; MESENCEPHALON; NERVE FIBERS; NEUROGLIA; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; TYROSINE 3-MONOOXYGENASE;

EID: 44649114567     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2008.03.070     Document Type: Article

References (38)

1. af Bjerkén S., Boger H.A., Nelson M., Hoffer B.J., Granholm A.-C., and Strömberg I. Effects of glial cell line-derived neurotrophic factor deletion on ventral mesencephalic organotypic tissue cultures. Brain Res. 1133 (2006) 10-19
2. Barroso-Chinea P., Cruz-Muros I., Aymerich M.S., Rodríguez-Díaz M., Afonso-Oramas D., Lanciego J.L., and González-Hernández T. Striatal expression of GDNF and different vulnerability of midbrain dopaminergic neurons. Eur. J. Neurosci. 21 (2005) 1815-1827
3. Berglöf E., af Bjerkén S., and Strömberg I. Glial influence on nerve fiber formation from rat ventral mesencephalic organotypic tissue culture. J. Comp. Neurol. 501 (2007) 431-442
4. Boka G., Anglade P., Wallach D., Javoy-Agid F., Agid Y., and Hirsch E.C. Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease. Neurosci. Lett. 172 (1994) 151-154
5. Carvey P.M., Chen E.-Y., Lipton J.W., Tong C.W., Chang Q.A., and Ling Z.D. Intra-parenchymal injection of tumor necrosis factor-α and interleukin 1-β produces dopamine neurons loss in the rat. J. Neural Transm. 112 (2005) 601-612
6. Choi S.J., Lee K.-H., Park H.S., Kim S.-K., Koh C.-M., and Park J.Y. Differential expression, shedding, cytokine regulation and function of TNFR1 and TNFR2 in human fetal astrocytes. Yonsei Med. J. 46 (2005) 818-826
7. Clarke D.J., and Branton R.L. A role for tumor necrosis factor α in death of dopaminergic neurons following neural transplantation. Exp. Neurol. 176 (2002) 154-162
8. Dahlström A., and Fuxe K. Evidence for the existence of monoamine-containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of the brain stem neurons. Acta Physiol. Scand., Suppl. 232 62 (1964) 1-55
9. Doherthy G.H. Developmental switch in the effects of TNFα on ventral midbrain dopaminergic neurons. Neurosci. Res. 57 (2007) 296-305
10. Duke D.C., Moran L.B., Pearce R.K.B., and Graeber M.B. The medial and lateral substantia nigra in Parkinson's disease: mRNA profiles associated with higher brain tissue vulnerability. Neurogenetics 8 (2007) 83-94
11. Dziewulska D., and Mossakowski M.J. Cellular expression of tumor necrosis factor α and its receptors in human ischemic stroke. Clin. Neuropathol. 22 (2003) 35-40
12. Ferger B., Leng A., Mura A., Hengerer B., and Feldon J. Genetic ablation of tumor necrosis factor-alpha (TNF-alpha) and pharmacological inhibition of TNF-synthesis attenuates MPTP toxicity in mouse striatum. J. Neurochem. 2004 (2004) 822-833
13. Figiel I., and Dzwonek K. TNFα and TNF receptor 1 expression in the mixed neuronal-glial cultures of hippocampal dentate gyrus exposed to glutamate or trimethyltin. Brain Res. 1131 (2007) 17-28
14. Fontaine V., Mohand-Said S., Hanoteau N., Fuchs C., Pfizenmaier K., and Eisel U. Neurodegenerative and neuroprotective effects of tumor necrosis factor (TNF) in retinal ischemia: opposite roles of TNF receptor 1 and TNF receptor 2. J. Neurosci. 22 (2002) RC216
15. Gemma C., Catlow B., Cole M., Hudson C., Samec A., Shah N., Vila M., Bachstetter A., and Bickford P.C. Early inhibition of TNFα increases 6-hydroxydopamine-induced striatal degeneration. Brain Res. 1147 (2007) 240-247
16. Gibb W.R. Melanin, tyrosine hydroxylase, calbindin and substance P in the human midbrain and substantia nigra in relation to nigrostriatal projections and differential neuronal susceptibility in Parkinson's disease. Brain Res. 581 (1992) 283-291
17. Gonzalo-Hernandez T., Barroso-Chinea P., De la Cruz Muros I., Del Mar Perez-Delgado M., and Rodriguez M. Expression of dopamine and vesicular monoamine transporters and differential vulnerability of mesostriatal dopaminergic neurons. J. Comp. Neurol. 479 (2004) 198-215
18. Gähwiler B.H., Capogna M., Debanne D., McKinney R.A., and Thompson S.M. Organotypic slice cultures: a technique has come of age. Trends Neurosci. 20 (1997) 471-477
19. Johansson S., and Strömberg I. Guidance of dopaminergic neuritic growth by immature astrocytes in organotypic cultures of rat fetal ventral mesencephalon. J. Comp. Neurol. 443 (2002) 237-249
20. Johansson S., and Strömberg I. Fetal lateral ganglionic eminence attracts one of two morphologically different types of tyrosine hydroxylase-positive nerve fibers formed by cultured ventral mesencephalon. Cell Transplant 12 (2003) 243-255
21. Kish S.J., Shannak K., and Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. New Engl. J. Med. 318 (1988) 876-880
22. Kolesnick R., and Golde D.W. The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell 77 (1994) 325-328
23. Kuno R., Yoshida Y., A., N., Nabeshima T., Wang J., Sonobe Y., Kawanokkuchi J., Takeuchi H., Mizuno T., and Suzumura A. The role of TNF-alpha and its receptors in the production of NGF and GDNF by astrocytes. Brain Res. 1116 (2006) 12-18
24. Lewis M., Tartaglia L.A., Lee A., Bennett G.L., Rice G.C., Wong G.H.W., Chen E.Y., and Goeddel D.V. Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific. Proc. Natl. Acad. Sci. 88 (1991) 2830-2834
25. McGeer E.G., and McGeer P.L. The role of immune system in neurodegenerative disorders. Mov. Dis. 12 (1997) 855-858
26. McGuire S.O., Ling Z.D., Lipton J.W., Sortwell C.E., Collier T.J., and Carvey P.M. Tumor necrosis factor α is toxic to embryonic mesencephalic dopamine neurons. Exp. Neurol. 169 (2001) 219-230
27. McNaught K.S.P., and Jenner P. Dysfunction of rat forebrain astrocytes in culture alters cytokine and neurotrophic factor release. Neursci. Lett. 285 (2000) 61-65
28. Mogi M., Harada M., Riederer P., Narabayashi H., Fujita K., and Nagatsu T. Tumor necrosis factor alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from Parkinsonian patients. Neurosci. Lett. 165 (1994) 208-210
29. Ouchi Y., Yoshikawa E., Sekine Y., Futatsubashi M., Kanno T., Ogusu T., and Torizuka T. Microglial activation and dopamine terminal loss in early Parkinson's disease. Ann. Neurol. 57 (2005) 168-175
30. Rousselet E., Callebert J., Parain K., Joubert C., Hunot S., Hartmann A., Jacque C., Perez-Diaz F., Cohen-Salomon C., Launay J.-M., and Hirsch E.C. Role of TNF-α receptors in mice intoxicatd with the parkinsonian toxin MPTP. Exp. Neurol. 177 (2002) 183-192
31. Sawada M., Imamura K., and Nagatsu T. The role of cytokines in inflammatory process in Parkinson's disease. J. Neural Transm., Suppl. 70 (2006) 373-381
32. Schluter C., M., D., Wohlenberg C., Becker M.H., Key G., Flad H.D., and Gerdes J. The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins. J. Cell Biol. 123 (1993) 513-522
33. Shinpo K., Kikuchi S., Moriwaka F., and Tashiro K. Protective effects of the TNF-ceramide pathway against glutamate neurotoxicity on cultured mesencephalic neurons. Brain Res. 819 (1990) 170-173
34. Sriram K., Matheson J.M., Benkovic S.A., Miller D.B., Luster M.I., and O'Callaghan J.P. Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: Implications for Parkinson's disease. FASEB J. 16 (2002) 1474-1476
35. Tacheuchi H., Jin S., Wang J., Zhang G., Kawanokuchi J., Kuno R., Sonobe Y., Mizuno T., and Suzumura A. Tumor necrosis factor-α induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner. J. Biol. Chem. 281 (2006) 21362-21368
36. Tartaglia L.A., Rothe M., Hu Y.F., and Goeddel D.V. Tumor necrosis factor's cytotoxic activity is signaled by the p55 TNF receptor. Cell 73 (1993) 213-216
37. Tartaglia L.A., Weber R.F., Figari I.S., Reynolds C., Palladino Jr. M.A., and Goeddlel D.V. The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc. Natl. Acad. Sci. 88 (1991) 9262-9296
38. Wessig J., Brecht S., Claussen M., Roemer L., Goetz M., Bigini P., Schutze S., and Herdegen T. Tumor necrosis factor-α receptor 1 (p55) knockout only transiently decreases the activation of c-Jun and does not affect the survival of axotomized dopaminergic nigral neurons. Eur. J. Neurosci. 22 (2005) 267-272